Walter Watts, MD
Radiation Oncology · Muskogee, OKNPI 1174784540
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,717 of the $10,479 with a category attached, or 73.6%. 52 manufacturers reported payments, led by Medtronic at 31.9% of the total. Reporting peaked in 2022 at $4,908 and has fallen 92.1% since, to $386 in 2025. Among radiation oncology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 372 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Lilly USA, LLC$769
- AstraZeneca$683
- Novartis$651
- Merck$568
- Johnson & Johnson$407
- plus $4K from 46 others
What the payments were for
- Speaking & faculty fees$2,40023%
- Food & beverage$7,71774%
- Education$3623%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OSTEOCOOL RF ABLATION SYSTEM$2,786
- OSTEOCOOL RF ABLATION$130
- Erleada$120
- DARZALEX$120
- RETEVMO$111
- TAGRISSO$110
How this compares
$10,479 in reported general payments places this provider in the 90th percentile of 43 radiation oncology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 15 | $106 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Muskogee
- Diane HeatonTulsa$36K
- Mykhanh NguyenTulsa$15K
- Jerry JaboinOklahoma City$14K
- Christina HensonOklahoma City$9K
- Kiran PrabhuOklahoma City$7K
- Nathan UyTulsa$5K
- Tyler GunterOklahoma City$3K
- Mark McLaughlinOklahoma City$3K
- Shripal BhavsarOklahoma City$3K
- Leslie YonemotoOklahoma City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.